ID   PM1015
AC   CVCL_UD97
SY   PM 1015
DR   cancercelllines; CVCL_UD97
DR   IARC_TP53; 5553
DR   Wikidata; Q98128642
RX   PubMed=7821846;
RX   PubMed=8557231;
CC   Doubling time: 48 hours (PubMed=7821846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=8557231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
RX   PubMed=7821846; DOI=10.1006/gyno.1995.1007;
RA   Buller R.E., Niemann T., Connor J.P., Squatrito R.C., Skilling J.S.,
RA   Anderson B.;
RT   "Isolation and preliminary characterization of an ovarian carcinoma
RT   cell line from a patient with familial ovarian cancer.";
RL   Gynecol. Oncol. 56:39-44(1995).
//
RX   PubMed=8557231; DOI=10.1006/gyno.1996.0014;
RA   Skilling J.S., Squatrito R.C., Connor J.P., Niemann T., Buller R.E.;
RT   "p53 gene mutation analysis and antisense-mediated growth inhibition
RT   of human ovarian carcinoma cell lines.";
RL   Gynecol. Oncol. 60:72-80(1996).
//